143 related articles for article (PubMed ID: 29138086)
21. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK
J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972
[TBL] [Abstract][Full Text] [Related]
22. Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets.
Magalhães J; Annunziato G; Franko N; Pieroni M; Campanini B; Bruno A; Costantino G
J Chem Inf Model; 2018 Mar; 58(3):710-723. PubMed ID: 29481752
[TBL] [Abstract][Full Text] [Related]
23. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations.
Shamim A; Abbasi SW; Azam SS
J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477
[TBL] [Abstract][Full Text] [Related]
24. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
25. Lipoxygenase directed anti-inflammatory and anti-cancerous secondary metabolites: ADMET-based screening, molecular docking and dynamics simulation.
Singh S; Awasthi M; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2017 Feb; 35(3):657-668. PubMed ID: 26942689
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the outer membrane subproteome of the virulent strain Salmonella Typhimurium SL1344.
Ferrer-Navarro M; Ballesté-Delpierre C; Vila J; Fàbrega A
J Proteomics; 2016 Sep; 146():141-7. PubMed ID: 27373869
[TBL] [Abstract][Full Text] [Related]
27. In-silico analysis of Sirt2 from Schistosoma mansoni: structures, conformations, and interactions with inhibitors.
Singh R; Singh S; Pandey PN
J Biomol Struct Dyn; 2016 May; 34(5):1042-51. PubMed ID: 26108803
[TBL] [Abstract][Full Text] [Related]
28. A multi-drug resistant Salmonella Typhimurium ST213 human-invasive strain (33676) containing the bla CMY-2 gene on an IncF plasmid is attenuated for virulence in BALB/c mice.
Wiesner M; Calva JJ; Bustamante VH; Pérez-Morales D; Fernández-Mora M; Calva E; Silva C
BMC Microbiol; 2016 Feb; 16():18. PubMed ID: 26862033
[TBL] [Abstract][Full Text] [Related]
29. Development of carbapenem resistance during therapy for non-typhoid Salmonella infection.
Su LH; Wu TL; Chiu CH
Clin Microbiol Infect; 2012 Apr; 18(4):E91-4. PubMed ID: 22329543
[TBL] [Abstract][Full Text] [Related]
30. In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
Ln R; Doble M; Rekha VP; Pulicherla KK
J Pediatr Hematol Oncol; 2011 Dec; 33(8):617-21. PubMed ID: 22042278
[TBL] [Abstract][Full Text] [Related]
31. In silico characterization of a cyanobacterial plant-type isoaspartyl aminopeptidase/asparaginase.
da Silva RC; Siqueira AS; Lima ARJ; de Melo Lima A; Santos AS; Aguiar DCF; Gonçalves EC
J Mol Model; 2018 Apr; 24(5):108. PubMed ID: 29619654
[TBL] [Abstract][Full Text] [Related]
32. Synergism in dual functionality of cryptdin-2 in conjunction with antibiotics against
Singh AP; Prabha V; Rishi P
Indian J Med Res; 2016 Nov; 144(5):761-770. PubMed ID: 28361830
[TBL] [Abstract][Full Text] [Related]
33. Treatment of severe Salmonella typhimurium infection with ciprofloxacin.
Dutta P; Saha MR; Mitra U; Rasaily R; Bhattacharya SK; Bhattacharya MK; Kundu B; Gupta A
Indian Pediatr; 1995 Jul; 32(7):804-7. PubMed ID: 8617560
[No Abstract] [Full Text] [Related]
34. Discovery of potent inhibitors targeting Vibrio harveyi LuxR through shape and e-pharmacophore based virtual screening and its biological evaluation.
Rajamanikandan S; Jeyakanthan J; Srinivasan P
Microb Pathog; 2017 Feb; 103():40-56. PubMed ID: 27939874
[TBL] [Abstract][Full Text] [Related]
35. Homology modeling and molecular docking studies to decrease glutamine affinity of Yarrowia lipolytica L-asparaginase.
Darvishi F; Beiranvand E; Kalhor H; Shahbazi B; Mafakher L
Int J Biol Macromol; 2024 Apr; 263(Pt 2):130312. PubMed ID: 38403216
[TBL] [Abstract][Full Text] [Related]
36. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
Arodola OA; Soliman ME
Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
[TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibility of multiple drug resistant Salmonella typhimurium to newer fluroquinolone derivatives.
Shetty M; Shivananda PG
Indian J Pathol Microbiol; 1995 Oct; 38(4):365-8. PubMed ID: 9726145
[TBL] [Abstract][Full Text] [Related]
38. Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands.
John A; Vetrivel U; Subramanian K; Deepa PR
J Biomol Struct Dyn; 2017 May; 35(6):1350-1366. PubMed ID: 27145135
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar.
Threlfall EJ; Ward LR; Skinner JA; Graham A
Microb Drug Resist; 2000; 6(4):319-25. PubMed ID: 11272261
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization, spread and evolution of multidrug resistance in Salmonella enterica typhimurium DT104.
Cloeckaert A; Schwarz S
Vet Res; 2001; 32(3-4):301-10. PubMed ID: 11432421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
